Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China

American Journal of Clinical Nutrition

Volumn 61, Issue 2, 1995, Pages 366-372

  He, Jiang ^a   Klag, Michael J ^b   Whelton, Paul K ^b   Mo, Jing Ping ^b   Chen, Jun Yun ^b   Qian, Ming Chu ^b   Mo, Pei Sheng ^b   He, Guan Qing ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHINA; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DIETARY INTAKE; ETHNIC GROUP; HIGH FIBER DIET; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OAT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WHEAT;

AVENA; TRITICUM AESTIVUM;

EID: 0028885348     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/61.2.366     Document Type: Article

References (54)

1. National Center for Health Statistics and the American Heart Association. Facts about cardiovascular disease. Circulation 1992;85:A103 (abstr).
2. World Health Organization. 1990 World health statistics annual. Geneva: World Health Organization, 1991.
3. Stokes J III, Kannel WB, Wolf PA. Blood pressure as a risk factor for cardiovascular disease. The Framingham study - 30 years of follow-up. Hypertension 1989;12(suppl 1):I-13-8.
4. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
5. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: U.S. population data. Arch Intern Med 1993;153:598-615.
6. Castelli WP, Anderson K, Wilson PWF, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 1992; 2:23-8.
7. Reed D, Benfante R. Lipid and lipoprotein predictors of coronary heart disease in elderly men in the Honolulu Heart program. Ann Epidemiol 1992;2:29-34.
8. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Levine DM. Serum cholesterol in youth and subsequent cardiovascular disease. N Engl J Med 1993;328:313-8.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program. JAMA 1991;265:3244-64.
10. Hypertension Detection and Follow-up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 1988; 259:2113-22.
11. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
12. Hebert P, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153: 578-81.
13. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, I: reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.
14. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, change in risk factors, and increased incidence of coronary heart disease. N Engl J Med 1987;317:1237-45.
15. Whelton PK, Adams-Campbell LL, Appel LJ, et al. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med 1993;153:186-208.
16. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
17. De Groot AP, Luyken R, Pikaar NA. Cholesterol - lowering effect of rolled oats. Lancet 1963;2:303-4.
18. Kirby RW. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981;34:824-9.
19. Anderson JW, Story L, Sieling B, Chen W-JL, Petro MS, Story J. Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr 1984;40:1146-55.
20. Demark-Wahnefried W, Bowering J, Cohen PS. Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets. J Am Diet Assoc 1990;90:223-9.
21. Anderson JW, Spencer DB, Hamilton CC, et al. Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am J Clin Nutr 1990;52:495-9.
22. Kestin M, Moss R, Clifton PM, Nestel PJ. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr 1990;52:661-6.
23. Horn LV, Moag-Stahlberg A, Liu K, et al. Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 1991;81:183-8.
24. Anderson JW, Gilinsky NH, Deakins DA, et al. Lipid response of hypercholesterolemic men to oat-bran and wheat bran intake. Am J Clin Nutr 1991;54:678-83.
25. Spiller GA, Farquhar JW, Gates TE, Nichols SF. Guar gum and plasma cholesterol. Effect of guar gum and oat fiber source on plasma lipoprotein and cholesterol in hypercholesterolemic adults. Arterioscler Thromb 1991;11:1204-8.
26. Davidson MH, Dugan LD, Burns JM, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of β-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 1991;265:1833-9.
27. Judd PA, Truswell AS. The effect of rolled oats on blood lipids and fecal steroid excretion in man. Am J Clin Nutr 1981;34:2061-7.
28. Horn LW, Liu K, Parker D, et al. Serum lipid response to oat product intake with a fat-modified diet. J Am Diet Assoc 1986;86:759-64.
29. Horn LW, Emidy LA, Liu K, et al. Serum lipid response to a fat-modified, oatmeal-enhanced diet. Prev Med 1988;17:377-86.
30. Gold K, Wong N, Tong A, et al. Serum apolipoprotein and lipid profile effects of an oat-bran-supplemented, low-fat diet in children with elevated serum cholesterol. Ann NY Acad Sci 1991;623:429-31.
31. Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 1990;322:147-52.
32. Birkeland KI, Gullestad L, Falch D, Torsvik H. Oat bran and serum cholesterol. N Engl J Med 1990;332:1748-9 (letter).
33. Institute of Nutrition of Chinese Academy of Medical Sciences. Chinese Food Composition Tables. 3rd ed. Beijing: People's Health Press, 1985.
34. He J, Klag MJ, Whelton PK, et al. Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol 1991;134: 1085-101.
35. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
36. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the calorimetric determination of serum triglycerides. Clin Chem 1983;29:538-42.
37. Keys A, Fidanza F, Karvonen MJ, Kumura N, Taylor HL. Indices of relative weight and obesity. J Chron Dis 1972;25:329-43.
38. SAS Institute Inc. SAS/STAT user's guide, release 6.03. Cary, NC: SAS Institute Inc, 1990.
39. Margetts BM, Beilin LJ, Vandongen R, Armstrong BK. A randomized controlled trial of the effect of dietary fiber on blood pressure. Clin Sci 1987;72:343-50.
40. Schlamowitz P, Halberg T, Warnoe O, Ryttig K. Treatment of mild to moderate hypertension with dietary fiber. Lancet 1987;2:622-3.
41. Rossner S, Anderson I-L, Ryttig K. Effects of a dietary fiber supplement to a weight reduction programme on blood pressure. A randomized, double-blind, placebo-controlled study. Acta Med Scand 1988; 223:353-7.
42. Ferrannini E, Shieh SM, Fun MT, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
43. Ferrannini E, Haffner SM, Stern MO. Essential hypertension: an insulin-resistance state. J Cardiovasc Parmacol 1990;15(suppl 5):s18-25.
44. Braaten JT, Wood PJ, Scott FW, Riedel KD, Poste LM, Collins MW. Oat gum lowers glucan and insulin after an oral glucose load. Am J Clin Nutr 1991;53:1425-30.
45. Wood PJ. Physicochemical properties and physiological effects of the (1→-3) (1→4)-β-D-Glucan from oats. In: Furda I, Brine CJ, eds. New developments in dietary fiber. New York: Plenum Press, 1990.
46. Ripsin CM. Oat products and lipid-lowering: a meta-analysis. Circulation 1992;85:864(abstr).
47. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14.
48. Shinnick FL, Ink SL, Marlett JA. Dose-response to a dietary oat bran fraction in the cholesterol-fed rat. J Nutr 1990;120:561-86.
49. Story JA, Kritchevsky D. Comparison of the binding of various bile acids and bile salts in vitro by several types of dietary fiber. J Nutr 1976;106:1292-4.
50. Vahouny GV, Tombes R, Cassidy MM, Kritchevsky D, Gallo LL. Dietary fiber V: Binding of bile salts, phospholipids and cholesterol from mixed micelles by bile acid sequestrants and dietary fibers. Lipids 1980;15:1012-8.
51. Story JA. Dietary fiber and lipid metabolism. Proc Soc Exp Biol Med 1985;180:447-52.
52. Anderson JW. Hypocholesterolemic effects of oat products. In: Furda I, Brine CJ, eds. New developments in dietary fiber. New York: Plenum Press, 1990.
53. Nyman MG-L, Asp N-GL. Fermentation of oat fiber in the rat intestinal tract: a study of different cellular areas. Am J Clin Nutr 1988; 48:274-8.
54. Anderson JW, Gustafson NJ. Hypocholesterolemic effects of oats and bean products. Am J Clin Nutr 1988;48:749-53.